Synapse - Works

Results (115370)

nab-Sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer: A phase II, open-label, single-arm, prospective, multicenter study

Meeting Abstract

Dockery, L.; Slomovitz, B.; Priebe, A.; Green, A.; Mathews, C.; Musa, F.; Puechl, A.; Birrer, M.; Spirtos, N.; Ding, L.; more...
Gynecologic Oncology (2024)

Fulltext@MSK | Save

UPLIFT (ENGOT-ov67/GOG-3048): Results from the phase II trial of upifitamab rilsodotin, a NaPi2b-directed dolaflexin antibody-drug conjugate, in platinum-resistant ovarian cancer

Meeting Abstract

Richardson, D.; Iyer, G.; Schmid, A.; Palma, N.; Navarro, W.; Ahnert, J. R.
Gynecologic Oncology (2024)

Fulltext@MSK | Save

Examining health-related quality of life outcomes among older patients with advanced ovarian cancer treated with niraparib first-line maintenance therapy in context with efficacy and safety findings: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial

Meeting Abstract

Pothuri, B.; Valabrega, G.; Oaknin, A.; Graybill, W.; Sánchez, A. B.; McCormick, C.; Baurain, J. F.; Tinker, A.; Denys, H.; O'Cearbhaill, R.; more...
Gynecologic Oncology (2024)

Fulltext@MSK | Save

A phase II, open-label, multicenter, basket study of the ATR kinase inhibitor ART0380 administered orally as monotherapy to patients with biologically selected advanced or metastatic solid tumors (ARTIST)

Meeting Abstract

Aghajanian, C.; Washington, C.; Moore, K.; Krivak, T.; Mathews, C.; Philip, T.; Konecny, G.; Fleming, G.; Martin, N.; Smith, G.; more...
Gynecologic Oncology (2024)

Fulltext@MSK | Save

A randomized, double-blind, phase II study of MK-4280A (coformulation of favezelimab and pembrolizumab) plus lenvatinib versus pembrolizumab plus lenvatinib among patients with previously-treated mismatch repair proficient advanced endometrial cancer

Meeting Abstract

Girda, E.; Makker, V.; Marth, C.; Van Gorp, T.; Mirza, M.; Shapira-Frommer, R.; Suttner, L.; Groisberg, R.; Jin, F.; O'Malley, D.
Gynecologic Oncology (2024)

Fulltext@MSK | Save

A phase I/II study of ubamatamab (REGN4018), a MUC16xCD3 bispecific antibody, administered alone or in combination with cemiplimab (anti-PD-1) in patients with recurrent ovarian cancer or MUC16+endometrial cancer: Trial in progress update

Meeting Abstract

Liu, J.; O'Malley, D.; Van Nieuwenhuysen, E.; O'Cearbhaill, R.; Bouberhan, S.; Moore, K.; Hou, J.; Hamilton, E.; Yoo, S. Y.; Wang, B.; more...
Gynecologic Oncology (2024)

Fulltext@MSK | Save

Oncologic and surgical outcomes of robotic-assisted versus conventional laparoscopy for the treatment of clinically uterineconfined high-grade endometrial carcinoma

Meeting Abstract

Dagher, C.; Sonoda, Y.; Roche, K. L.; Jewell, E.; Chi, D.; Gardner, G.; Mueller, J.; Broach, V.; Abu-Rustum, N.; Leitao, M.
Gynecologic Oncology (2024)

Fulltext@MSK | Save

Oncologic outcomes of minimally invasive surgery versus laparotomy for the treatment of 2009 FIGO stage II endometrial cancer

Meeting Abstract

Dagher, C.; Mueller, J.; Sonoda, Y.; Broach, V.; Abu-Rustum, N.; Leitao, M.
Gynecologic Oncology (2024)

Fulltext@MSK | Save

Hypoalbuminemia alone is not a contraindication to primary cytoreductive surgery in advanced ovarian cancer

Meeting Abstract

Finch, L.; Dagher, C.; Finlan, M.; Kahn, R.; Yeoshoua, E.; Broach, V.; Roche, K. L.; Gardner, G.; Sonoda, Y.; Abu-Rustum, N.; more...
Gynecologic Oncology (2024)

Fulltext@MSK | Save

Evaluating the risks of pleural effusions and chest tube placement at the time of cytoreductive surgery for advanced ovarian cancer

Meeting Abstract

Kahn, R.; Tian, E.; Yeoshoua, E.; Zhou, Q.; Iasonos, A.; Gardner, G.; Roche, K. L.; Sonoda, Y.; Zivanovic, O.; Abu-Rustum, N.; more...
Gynecologic Oncology (2024)

Fulltext@MSK | Save